Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2008
10/08/2008EP1976519A2 Cytisine and acetylcholine analogs and methods of treating mood disorders
10/08/2008EP1976515A2 Combination therapy with parp inhibitors
10/08/2008EP1778680B1 Spirocyclic cyclohexane derivatives
10/08/2008EP1641799B8 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments
10/08/2008EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/08/2008EP1606283B1 P38 inhibitors and methods of use thereof
10/08/2008EP1569931B1 Heterocyclic compounds as ccr5 antagonists
10/08/2008EP1478628B1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
10/08/2008EP1412078B1 Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one, gemifloxacin or a salt thereof
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008CN101283071A Compositions containing fluorine substituted olefins
10/08/2008CN101282975A Compounds and compositions as protein kinase inhibitors
10/08/2008CN101282974A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101282973A Imidazopyridine derivatives as cannabinoid receptor ligands
10/08/2008CN101282972A Piperidine and piperazine derivatives as P2X3 antagonists
10/08/2008CN101282960A RAF inhibitor compounds and methods
10/08/2008CN101282932A Carboxyamine compounds and their use in the treatment of HDAC dependent diseases
10/08/2008CN101282930A Fab I inhibitor and process for preparing same
10/08/2008CN101279973A Preparation of 1,8-diazabicyclo[5.4.0]undec-7-ene
10/08/2008CN101279969A Organic electroluminescent material and application thereof
10/08/2008CN100424082C 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists
10/07/2008US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
10/07/2008US7432375 JNK inhibitors
10/07/2008US7432371 Nanofilm and membrane compositions
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432283 Heterocyclic GABAA subtype selective receptor modulators
10/07/2008US7432279 serine/threonine protein kinases inhibitors, TNF- alpha synthesis inhibitors; antiinflammatory agents; rheumatoid arthritis; 4-(3-chloro-4-fluorophenylamino)-6-(pyridin-3-ylmethylamino)-1,7-naphthyridine-3-carbonitrile; oral adminitration; small molecules
10/07/2008US7432278 Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents
10/07/2008US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432267 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile
10/07/2008US7432266 Phosphodiesterase 4 inhibitors
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008CA2427573C Indole derivatives as pde5-inhibitors
10/07/2008CA2305926C Stable crystalline salts of 5-methyltetrahydrofolic acid
10/02/2008WO2008118747A1 Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
10/02/2008WO2008118745A1 4-substituted azaadamantane derivatives and methods of use thereof
10/02/2008WO2008118743A1 Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
10/02/2008WO2008118742A1 Azaadamantane ester and carbamate derivatives and methods of use thereof
10/02/2008WO2008118718A2 2-aminopyridine analogs as glucokinase activators
10/02/2008WO2008118485A1 Novel imidazo based heterocycles
10/02/2008WO2008118454A2 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
10/02/2008WO2008117796A1 Novel mutilin derivatives
10/02/2008WO2008117269A2 Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof
10/02/2008WO2008117225A2 New imidazolo-heteroaryl derivatives with antibacterial properties
10/02/2008WO2008116833A1 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008WO2008116665A1 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
10/02/2008WO2008116304A1 Naphthalene and quinoline sulfonylurea derivatives as ep4 receptor antagonists
10/02/2008WO2008100618A3 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/02/2008WO2008099377A3 Imiquimod production process
10/02/2008WO2008093024A3 N-(amino-heteroaryl)-1h-pyrrolopyridine-2-carboxamides derivatives, preparation thereof and their use in therapy
10/02/2008WO2008092877A3 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
10/02/2008WO2008084223A3 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
10/02/2008WO2008082490A3 Novel jnk inhibitors
10/02/2008WO2008080015A3 Compounds and methods for kinase modulation, and indications therefor
10/02/2008WO2008075172A3 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
10/02/2008WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors
10/02/2008WO2008071456A3 3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
10/02/2008WO2008009076A3 Substituted pyrido(3,2-d)pyrimidines and pharmaceutical compositions for treating viral infections
10/02/2008WO2007133561A3 Substituted azaspiro derivatives
10/02/2008WO2007044893A3 Compounds and methods for inhibiting hepatitis c viral replication
10/02/2008US20080242695 Certain Chemical Entities, Compositions, and Methods
10/02/2008US20080242685 Chemical Compounds
10/02/2008US20080242658 Inhibitors of Iap
10/02/2008US20080242655 Aza-indolyl compounds and methods of use
10/02/2008CA2682221A1 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
10/02/2008CA2681739A1 Novel imidazo based heterocycles
10/02/2008CA2681695A1 2-aminopyridine analogs as glucokinase activators
10/02/2008CA2681393A1 New imidazolo-heteroaryl derivatives and biological applications thereof
10/02/2008CA2681146A1 Naphthalene and quinoline sulfonylurea derivatives as ep4 receptor antagonists
10/02/2008CA2681034A1 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008CA2679885A1 Aminomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
10/02/2008CA2679876A1 4-substituted azaadamantane derivatives and methods of use thereof
10/02/2008CA2679874A1 Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
10/02/2008CA2679870A1 Azaadamantane ester and carbamate derivatives and methods of use thereof
10/01/2008EP1975205A1 Trisazo compound, ink composition, recording method and colored matter
10/01/2008EP1975160A1 Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method
10/01/2008EP1974729A1 Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
10/01/2008EP1974212A1 Compounds useful in cftr assays and methods therewith
10/01/2008EP1973914A2 Transforming growth factor modulators
10/01/2008EP1973913A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives
10/01/2008EP1973912A2 Tetrabenzodiazadiketoperylene colourants in ir-reflective coatings and plastics
10/01/2008EP1973911A2 Azaindoles useful as inhibitors of janus kinases
10/01/2008EP1973910A1 Pyrrolo ý3,2-c¨pyridine-4-one 2-indolinone protein kinase inhibitors
10/01/2008EP1973909A2 Transforming growth factor modulators
10/01/2008EP1973908A2 Processes and intermediates useful for preparing integrase inhibitor compounds
10/01/2008EP1973907A1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
10/01/2008EP1973906A1 Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
10/01/2008EP1973904A2 Muscarinic agonists and methods of use thereof
10/01/2008EP1973902A2 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
10/01/2008EP1973900A1 Hydantoin compounds for the treatment of inflammatory disorders
10/01/2008EP1973898A1 Pdf inhibitors
10/01/2008EP1973545A2 Bicyclic heteroaryl compounds
10/01/2008EP1973543A2 Modulators of muscarinic receptors
10/01/2008EP1641454B1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors
10/01/2008EP1622903B1 Cannabinoid receptor ligands and uses thereof
10/01/2008CN101277960A Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
10/01/2008CN101277959A Process for preparing zolpidem hemitartrate and tartrate polymorphs
10/01/2008CN101277958A Naphthyridin derivatives
10/01/2008CN101277957A Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 646